当前位置:首页 - 行情中心 - 三诺生物(300298) - 财务分析 - 现金流量表

三诺生物

(300298)

  

流通市值:103.69亿  总市值:128.54亿
流通股本:4.55亿   总股本:5.64亿

现金流量表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金3,106,996,210.952,032,117,401.76730,480,401.922,986,144,952.17
收到的税费返还74,158,541.8153,166,154.2821,956,427.2151,987,299.12
收到其他与经营活动有关的现金23,515,625.6123,080,903.4312,617,613.361,496,353.47
经营活动现金流入的平衡项目0000
经营活动现金流入小计3,204,670,378.372,108,364,459.47765,054,442.433,099,628,604.76
购买商品、接受劳务支付的现金1,128,312,089.68715,460,853.66241,479,873.61,117,501,895.73
支付给职工以及为职工支付的现金808,294,518.84587,321,174.13243,507,644.95663,564,735.01
支付的各项税费188,234,179.54125,486,520.6260,580,314.14253,021,033.5
支付其他与经营活动有关的现金670,025,783428,628,232.59159,332,557.64591,154,377.72
经营活动现金流出的平衡项目0000
经营活动现金流出小计2,794,866,571.061,856,896,781704,900,390.332,625,242,041.96
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额409,803,807.31251,467,678.4760,154,052.1474,386,562.8
二、投资活动产生的现金流量:
收回投资收到的现金35,000,00035,000,00036,000,000333,075,651
取得投资收益收到的现金1,155,022.24131,60014,0003,516,608.95
处置固定资产、无形资产和其他长期资产收回的现金净额30,933.626,013.626,003.6346,043.77
收到的其他与投资活动有关的现金---638,662.44
投资活动现金流入的平衡项目0000
投资活动现金流入小计36,185,955.8435,157,613.636,040,003.6337,576,966.16
购建固定资产、无形资产和其他长期资产支付的现金260,358,036.35137,479,447.0675,526,570.72311,185,350.07
投资支付的现金35,000,00035,000,000142,900,000160,075,651
投资活动现金流出的平衡项目0000
投资活动现金流出小计295,358,036.35172,479,447.06218,426,570.72471,261,001.07
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-259,172,080.51-137,321,833.46-182,386,567.12-133,684,034.91
三、筹资活动产生的现金流量:
吸收投资收到的现金18,000,00018,000,00018,000,00018,000,000
其中:子公司吸收少数股东投资收到的现金18,000,00018,000,00018,000,00018,000,000
取得借款收到的现金587,165,210.61497,165,210.6120,000,000273,998,823.05
收到其他与筹资活动有关的现金208,858,809.8148,824,218.13149,199,504.13345,509,148.74
筹资活动现金流入平衡项目0000
筹资活动现金流入小计814,024,020.41663,989,428.74187,199,504.13637,507,971.79
偿还债务支付的现金945,913,584.81447,015,123.8320,000,000436,046,191.63
分配股利、利润或偿付利息支付的现金136,404,768.69128,959,500.76553,985.34117,429,143.7
支付其他与筹资活动有关的现金69,072,746.1936,612,409.641,935,859.08367,536,096.29
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,151,391,099.69612,587,034.2322,489,844.42921,011,431.62
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-337,367,079.2851,402,394.51164,709,659.71-283,503,459.83
四、汇率变动对现金及现金等价物的影响1,878,457.7210,542,095.81,162,141.14,802,488.94
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-184,856,894.76176,090,335.3243,639,285.7962,001,557
加:期初现金及现金等价物余额810,516,702.07810,516,702.07649,264,325.35590,023,224.68
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额625,659,807.31986,607,037.39692,903,611.14652,024,781.68
补充资料:
净利润-139,520,349.94-427,956,052.92
资产减值准备-9,281,203.44-34,424,089.8
固定资产和投资性房地产折旧-92,599,089.16-70,028,668.95
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-92,599,089.16-70,028,668.95
无形资产摊销-27,293,023.24-34,036,787.39
长期待摊费用摊销-3,458,616.34-6,248,744.34
处置固定资产、无形资产和其他长期资产的损失-3,064,620.48-367,286.14
固定资产报废损失-404.4--
财务费用-32,479,204.95-17,689,469.63
投资损失--105,653.69--42,064,116.28
递延所得税-14,746,166.11--13,459,006.07
其中:递延所得税资产减少-9,664,491.7--4,850,784.79
递延所得税负债增加-5,081,674.41--8,608,221.28
存货的减少-47,375,530.52--83,406,584.65
经营性应收项目的减少--57,703,647.45--111,508,848.01
经营性应付项目的增加--60,541,228.97-124,986,026.65
现金的期末余额-986,607,037.39-652,024,781.68
减:现金的期初余额-810,516,702.07-590,023,224.68
公告日期2023-10-242023-08-302023-04-252023-04-07
审计意见(境内)标准无保留意见
TOP↑